Explore
Validate
LearnOAAB02287
antibody from Aviva Systems Biology
Targeting: TXNDC12
AGR1, ERP18, ERP19, hAG-1, PDIA16, TLP19
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- OAAB02287 - Provider product page
- Provider
- Aviva Systems Biology
- Product name
- TXNDC12 antibody - C-terminal region
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Vial size
- 400ul
- Storage
- Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles.
No comments: Submit comment
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Western blot analysis of TXNDC12 Antibody (C-term) in mouse stomach tissue lysates (35ug/lane). TXNDC12 (arrow) was detected using the purified Pab.
- Sample type
- mouse stomach tissue lysates
- Primary Ab dilution
- 1.0 µg/mL
- Protocol
- Protocol
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Western blot analysis of TXNDC12 Antibody (C-term) in Y79 cell lysates (35ug/lane). TXNDC12 (arrow) was detected using the purified Pab.
- Sample type
- Y79 cell line lysates
- Primary Ab dilution
- 1.0 µg/mL
- Protocol
- Protocol
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- TXNDC12 Antibody (C-term) IHC analysis in formalin fixed and paraffin embedded prostate carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the TXNDC12 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
- Sample type
- prostate carcinoma
- Primary Ab dilution
- 1.0 µg/mL
- Protocol
- Protocol
